Look for:

Our offer for

ASTRAZENECA PLC


ISIN:
GB0009895292
WKN:
0989529

2022/09/29 15:20:44
Price
1,232.00 SEK
Difference 0.20% (2.50)

General attributes

ISINGB0009895292
SymbolAZN
ExchangeNasdaq Stockholm
CurrencySEK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)174,223 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)1,232.00 SEK (72)
Ask (Ask size)1,232.50 SEK (389)
Open1,228.00 SEK
High1,237.00 SEK
Low1,210.50 SEK
Close (prev. day)1,229.50 SEK
VWAP1,225.356323 SEK
Volume (pcs)297,553
Trading volume364,612,208.50
Number of trades3,345
Last size50

Futures and Options

Related Futures48
Related Options-

PDF Downloads

Company report: ASTRAZENECA PLCPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2022/09/26 en Global Equity Ratings PDF Download
2022/09/01 en Global Equity Ratings PDF Download
2022/08/25 en Global Equity Ratings PDF Download
2022/08/18 en Global Equity Ratings PDF Download
2022/08/08 en Global Equity Ratings PDF Download


2022/09/29 15:20:44
Price
1,232.00 SEK
Difference 0.20% (2.50)

General attributes

ISINGB0009895292
SymbolAZN
ExchangeNasdaq Stockholm
CurrencySEK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)174,223 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)1,232.00 SEK (142)
Ask (Ask size)1,232.50 SEK (180)
Open1,228.00 SEK
High1,237.00 SEK
Low1,210.50 SEK
Close (prev. day)1,229.50 SEK
VWAP1,225.356323 SEK
Volume (pcs)297,553
Trading volume364,612,208.50
Number of trades3,345
Last size50

Performance and Risk

6m1Y3Y
Perf (%)-0.91%+22.95%+37.82%
Perf (abs.)-11.30+229.50+337.40
Beta0.750.850.59
Volatility23.3525.2526.65
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1,228.90 SEK (452,415)
Ø price 30 days | Ø volume 30 days (pcs.)1,315.37 SEK (416,380)
Ø price 100 days | Ø volume 100 days (pcs.)1,319.57 SEK (424,155)
Ø price 250 days | Ø volume 250 days (pcs.)1,196.88 SEK (469,590)
YTD High | date1,456.50 SEK (2022/08/22)
YTD Low | date1,018.60 SEK (2022/02/07)
52 Weeks High | date1,456.50 SEK (2022/08/22)
52 Weeks Low | date978.10 SEK (2021/12/13)

All listings for ASTRAZENECA PLC

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/09/2915:17112.65 EUR0.2232
Tradegate2022/09/2914:45112.50 EUR0.0514
Stuttgart2022/09/2911:27112.10 EUR0.008
SIX Swiss Exchange2022/04/1417:3595.03 CHF0.001
Nasdaq Stockholm2022/09/2915:201,232.00 SEK364.613,345
Munich2022/09/2908:00111.70 EUR0.001
London Stock Exchange2022/09/2915:219,976.00 GBp5,814.979,145
Hanover2022/09/2908:01111.70 EUR0.001
Hamburg2022/09/2908:01111.70 EUR0.001
Frankfurt2022/09/2914:44112.40 EUR0.045
FINRA other OTC Issues2022/09/2821:00108.26 USD0.4630
Duesseldorf2022/09/2915:01112.65 EUR0.008
Berlin2022/09/2908:08111.90 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=475&ID_TYPE_IMAGE_LOGO=2

Contact Details

ASTRAZENECA PLC
- -
Cambridge Biomedical Campus - CB2 0AA Cambridge
Telefon: 44-20-3749-5000
Fax: 44-12-2335-2858
E-mail: -

PDF Downloads

Company report: ASTRAZENECA PLCPDF Download

Company Profile

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. It focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. These pharmaceutical products are then manufactured, marketed and sold. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Members of Management Board

Pascal SoriotChairman of Managing Board
Aradhana SarinMember of Executive Committee
David FredricksonMember of Executive Committee
Iskra ReicMember of Executive Committee
Jeff PottMember of Executive Committee
Leon WangMember of Executive Committee
Marc DunoyerMember of Executive Committee
Menelas PangalosMember of Executive Committee
Pam ChengMember of Executive Committee
President AstraZeneca AB, SwedenMember of Executive Committee
Ruud DobberMember of Executive Committee
Susan GalbraithMember of Executive Committee

Board of directors

Leif Valdemar JohanssonChairman of Supervisory Board
Andreas RummeltMember of Supervisory Board
Aradhana SarinMember of Supervisory Board
Euan AshleyMember of Supervisory Board
Nazneen RahmanMember of Supervisory Board
Tony MokMember of Supervisory Board
Deborah DiSanzoMember of Supervisory Board
Diana LayfieldMember of Supervisory Board
Marcus WallenbergMember of Supervisory Board
Michel DemaréMember of Supervisory Board
Philip BroadleyMember of Supervisory Board
Sherilyn McCoyMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer